{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:08:38Z","timestamp":1792786118336,"version":"4.5.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T00:00:00Z","timestamp":1528243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/3\/"}],"funder":[{"name":"Mucopolysaccharide Diseases"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1093\/qjmed\/hcy120","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T15:08:52Z","timestamp":1528124932000},"page":"3-9","source":"Crossref","is-referenced-by-count":15,"title":["Diagnosis and treatment of the cardiovascular consequences of Fabry disease"],"prefix":"10.1093","volume":"112","author":[{"given":"S","family":"Baig","sequence":"first","affiliation":[{"name":"Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK"},{"name":"Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Vijapurapu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK"},{"name":"Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Central Military Laboratory and Blood Bank, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nordin","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Kozor","sequence":"additional","affiliation":[{"name":"Sydney Medical School, University of Sydney, Camperdown, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Moon","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Bembi","sequence":"additional","affiliation":[{"name":"Centre for Rare Diseases, AMC Hospital of Udine, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Geberhiwot","sequence":"additional","affiliation":[{"name":"Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R P","family":"Steeds","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK"},{"name":"Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,6]]},"reference":[{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2013-101857","article-title":"A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance","volume":"51","author":"Van der Tol","year":"2014","journal-title":"J Med Genet"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B2","doi-asserted-by":"crossref","first-page":"e001639","DOI":"10.1161\/CIRCGENETICS.116.001639","article-title":"Fabry disease in families with hypertrophic cardiomyopathy: clinical manifestations in classic and later-onset phenotypes","volume":"10","author":"Adalsteinsdottir","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B3","volume-title":"Cochrane Database of Systematic Reviews","author":"El Dib","year":"2016"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehp387","article-title":"Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease","volume":"31","author":"Brakch","year":"2010","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B5","doi-asserted-by":"crossref","first-page":"e002839.","DOI":"10.1161\/JAHA.115.002839","article-title":"High-sensitivity troponin: a clinical blood biomarker for staging cardiomyopathy in Fabry disease","volume":"5","author":"Seydelmann","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B6","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jacc.2016.07.741","article-title":"Cardiac Fabry disease with late gadolinium enhancement is a chronic inflammatory cardiomyopathy","volume":"68","author":"Nordin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B7","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","article-title":"Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey","volume":"28","author":"Linhart","year":"2007","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/CIRCHEARTFAILURE.108.769729","article-title":"Angina in Fabry disease reflects coronary small vessel disease","volume":"1","author":"Chimenti","year":"2008","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B9","first-page":"1","article-title":"Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice","author":"Baig","year":"2017","journal-title":"Europace"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.amjcard.2016.04.033","article-title":"Usefulness of implantable loop recorder to detect clinically relevant arrhythmia in patients with advanced Fabry cardiomyopathy","volume":"118","author":"Weidemann","year":"2016","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/eurheartj\/ehp426","article-title":"Aortic remodelling in Fabry disease","volume":"31","author":"Barbey","year":"2010","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10545-017-0127-2","article-title":"Globotriaosylsphingosine (lyso-Gb3) as a biomarker for cardiac variant (N215S) Fabry disease","volume":"41","author":"Alharbi","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/hrt.2010.211789","article-title":"Electrocardiographic changes in early recognition of Fabry disease","volume":"97","author":"Namdar","year":"2011","journal-title":"Heart"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B14","doi-asserted-by":"crossref","first-page":"S107.","DOI":"10.1016\/j.ymgme.2017.12.283","article-title":"The subclinical phenotype of cardiac Fabry disease","volume":"123","author":"Nordin","year":"2018","journal-title":"Mol Gen Metab"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B15","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/heartjnl-2015-308897","article-title":"The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy","volume":"102","author":"Schmied","year":"2016","journal-title":"Heart"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/eurheartj\/ehi143","article-title":"The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease","volume":"26","author":"Weidemann","year":"2005","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.echo.2013.09.005","article-title":"Systolic and diastolic function assessment in Fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements","volume":"26","author":"Shanks","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.echo.2016.10.014","article-title":"Impaired left atrial function in Fabry disease: a longitudinal speckle-tracking echocardiography study","volume":"30","author":"Pichette","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B19","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/ehjci\/jew187","article-title":"Insight into hypertrophied hearts: a cardiovascular magnetic resonance study of papillary muscle mass and T1 mapping","volume":"18","author":"Kozor","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B20","doi-asserted-by":"crossref","first-page":"14.","DOI":"10.1186\/s12968-016-0233-6","article-title":"Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease","volume":"18","author":"Deva","year":"2016","journal-title":"J Soc Cardiovasc Magn Reson"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B21","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","article-title":"Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease evidence for a disease specific abnormality of the myocardial interstitium","volume":"24","author":"Moon","year":"2003","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10554-018-1320-6","article-title":"Clinical applications of multiparametric CMR in left ventricular hypertrophy","volume":"34","author":"Nordin","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B23","doi-asserted-by":"crossref","first-page":"e007168","DOI":"10.1161\/CIRCIMAGING.117.007168","article-title":"The cardiac phenotype of pre-hypertrophic Fabry disease","volume":"11","author":"Nordin","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B24","article-title":"Proposed stages of myocardial phenotype development in Fabry disease","author":"Nordin","year":"2018","journal-title":"JACC: Imaging"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B25","doi-asserted-by":"crossref","first-page":"e003073.","DOI":"10.1161\/CIRCIMAGING.114.003073","article-title":"Performance of T1 and T2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure","volume":"8","author":"Bohnen","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/8904_2015_502","article-title":"Electrical changes in resting, exercise, and Holter electrocardiography in Fabry cardiomyopathy","volume":"28","author":"Kr\u00e4mer","year":"2016","journal-title":"JIMD Rep"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B27","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00259-015-3036-3","article-title":"First experience of simultaneous PET\/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease","volume":"42","author":"Nappi","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B28","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s00259-017-3778-1","article-title":"Cardiac sympathetic neuronal damage precedes myocardial damage in patients with Anderson-Fabry disease","volume":"44","author":"Imbriaco","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B29","first-page":"e0157640","volume-title":"PLoS One","author":"Tanislav","year":"2016"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B30","doi-asserted-by":"crossref","first-page":"e0140627.","DOI":"10.1371\/journal.pone.0140627","article-title":"Left ventricular geometry and blood pressure as predictors of adverse progression of Fabry cardiomyopathy","volume":"10","author":"Kr\u00e4mer","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B31","doi-asserted-by":"crossref","first-page":"232640981666135.","DOI":"10.1177\/2326409816661352","article-title":"Cardiac manifestation of Fabry disease: from hypertrophic cardiomyopathy to early diagnosis and treatment in patients with left ventricular hypertrophy","volume":"4","author":"Fern\u00e1ndez","year":"2016","journal-title":"J Inborn Err Metab Scr"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/1566523218666180404161315","article-title":"Genetics and gene therapy of Anderson-Fabry disease","volume":"18","author":"Simonetta","year":"2018","journal-title":"Curr Gene Ther"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B33","doi-asserted-by":"crossref","first-page":"36.","DOI":"10.1186\/s13023-015-0253-6","article-title":"Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document","volume":"10","author":"Biegstraaten","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B34","doi-asserted-by":"crossref","first-page":"125.","DOI":"10.1186\/s13023-015-0338-2","article-title":"Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years\u2019 treatment","volume":"10","author":"Kampmann","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B35","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/gim.2016.122","article-title":"The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat","volume":"19","author":"Benjamin","year":"2017","journal-title":"Genet Med"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jmedgenet-2016-104178","article-title":"Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study","volume":"54","author":"Hughes","year":"2017","journal-title":"J Med Genet"},{"key":"key\n\t\t\t\t2019010207490105000_hcy120-B37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1510198","article-title":"Treatment of Fabry disease with the pharmacological chaperone migalastat","volume":"375","author":"Germain","year":"2016","journal-title":"N Engl J Med"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/112\/1\/3\/27363936\/hcy120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T22:11:51Z","timestamp":1571436711000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/112\/1\/3\/5033833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,6]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,6,6]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcy120","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,6,6]]}}}